Closing soonScience & R&D
Closes in 15 daysU.S. National Science Foundation · PD-20-1264
The Algebra and Number Theory program supports research in algebra, algebraic and arithmetic geometry, number theory, and representation theory. Conference proposals The Algebra and Number Theory program also provides support for conferences, workshops, summer/winter schools,…
Amount not listedDue Oct 9, 2026
Closing soonAI & machine learningU01Clinical trial: Not allowed
Closes in 15 daysNIH Common Fund (NIH-CF) · RFA-RM-27-011
The overarching goal of this notice of funding opportunity (NOFO) and its companion opportunities is to establish the Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) Program to support development of innovative, reliable, cost-effective, and…
Biomarkers & diagnostics
Up to $300KDue Oct 9, 2026
Closing soonScience & R&D
Closes in 15 daysU.S. National Science Foundation · 24-590
The NSF Directorate for Engineering (ENG) seeks to build engineering research capacity across the nation by investing in new academic investigators who have yet to receive sufficient research funding from Federal Agencies. The Engineering Research Initiation (ERI) program will…
From $200KDue Oct 9, 2026
Closing soonAI & machine learningBasic science (physics, chemistry, math)
Closes in 15 daysU.S. National Science Foundation · 24-569
Machine Learning and Artificial Intelligence (AI) are enabling extraordinary scientific breakthroughs in fields ranging from protein folding, natural language processing, drug synthesis, and recommender systems to the discovery of novel engineering materials and products. These…
Therapeutics & drug discovery
$500K – $1.5MDue Oct 9, 2026
Closing soonMental health & psychiatricU01Clinical trial: Required
Closes in 15 daysNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · RFA-DK-27-121
This Notice of Funding Opportunity (NOFO) invites applications from clinical centers to participate in a consortium to test anti-obesity medication (AOM) treatment strategies for youth with obesity that maximize benefits and minimize risks of AOM use. Such intervention…
Basic mechanisms & biologyTherapeutics & drug discoveryCare & caregivingPrevention & risk factors
Closing soonMental health & psychiatricU24Clinical trial: Not allowed
Closes in 15 daysNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · RFA-DK-27-136
This Notice of Funding Opportunity (NOFO) invites applications for a Research Coordinating Center (RCC) to participate in a consortium of clinical centers that will test anti-obesity medication (AOM) treatment strategies for youth with obesity that maximize benefits and minimize…
Basic mechanisms & biologyTherapeutics & drug discoveryCare & caregivingPrevention & risk factorsData & infrastructure
Closing soonScience & R&D
Closes in 15 daysDept of the Army -- Materiel Command · W911NF26S0105
Under the authority of 10 U.S.C. § 4144, in alignment with Section 223 of the FY 2026 National Defense Authorization Act (NDAA), funding in the FY 2026 defense appropriations, and, Presidential Executive Order 14332, Improving Oversight of Federal Grantmaking, the DoW announces…
Health disparities
$200K – $1.5MDue Oct 9, 2026
Closing soonScience & R&D
Closes in 15 daysDARPA — Defense Advanced Research Projects Agency · DARPA-PA-25-07-06
Broad Agency Announcement (BAA) on SAM.gov — see the notice for research topics and key dates.
Amount not listedDue Oct 9, 2026
Closing soonHealthR01Clinical trial: Required
Closes in 17 daysNational Institute of Mental Health (NIMH) · RFA-MH-27-135
The purpose of this notice of funding opportunity (NOFO) is to elucidate the key components of the therapeutic effects of rapid-acting psychotropic interventional drugs (RAPIDs) by addressing the methodological challenges involved with these clinical trials. In addition, this…
Therapeutics & drug discoveryClinical trials
$5.5M totalDue Oct 11, 2026≈10% funded · FY25
Closing soonAlzheimer's & dementia (ADRD)Clinical trial: Optional / allowed
Closes in 20 daysAlzheimer's Association
Supports early-career clinician-scientists pursuing dementia research alongside clinical training. Curated entry; verify current terms at the program page.
Training & career developmentClinical trials
Up to $175KDue Oct 14, 2026
Closing soonAlzheimer's & dementia (ADRD)Clinical trial: Not allowed
Closes in 20 daysAlzheimer's Association
Supports postdoctoral fellows to conduct dementia research and build toward research independence. Curated entry; verify current terms at the program page.
Training & career development
Up to $175KDue Oct 14, 2026
Closing soonAlzheimer's & dementia (ADRD)Clinical trial: Optional / allowed
Closes in 20 daysAlzheimer's Association
Funds investigators early in their independent careers to develop new ideas across AD/ADRD biology, diagnosis, and treatment. Curated entry; verify current terms at the program page.
Basic mechanisms & biologyBiomarkers & diagnosticsTherapeutics & drug discovery
Up to $200KDue Oct 14, 2026
Closing soonCancer & oncologyUH2Clinical trial: Not allowed
Closes in 20 daysNational Institutes of Health (NIH) · PAR-25-074
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) invites applications to support the validation of molecular/cellular/imaging markers (referred to as "markers" or "biomarkers") and assays for cancer detection, diagnosis, prognosis,…
Basic mechanisms & biologyBiomarkers & diagnosticsTherapeutics & drug discoveryClinical trialsPrevention & risk factorsData & infrastructure
Amount not listedDue Oct 14, 2026
Closing soonCancer & oncologyUH3Clinical trial: Not allowed
Closes in 20 daysNational Institutes of Health (NIH) · PAR-25-075
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to accelerate the adoption and validation of molecular/cellular/imaging markers (referred to as "markers" or "biomarkers") and assays for cancer detection, diagnosis, prognosis,…
Basic mechanisms & biologyBiomarkers & diagnosticsTherapeutics & drug discoveryClinical trialsPrevention & risk factorsData & infrastructure
Up to $250KDue Oct 14, 2026
Closing soonCancer & oncology
Closes in 20 daysDept. of Defense — CDMRP · HT942526MRPFPARM
Summary: The fiscal year 2026 (FY26) Melanoma Research Program (MRP) Focused Program Award – Rare Melanomas, supports a multidisciplinary research program of at least two, but not more than three, distinct but complementary research projects addressing an overarching question…
Basic mechanisms & biologyClinical trials
$5.6M totalDue Oct 14, 2026